Utah Medical Products (UTMD) Return on Capital Employed (2011 - 2026)

Utah Medical Products' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 9.01% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 187.0% year-over-year to 9.01% in Q1 2026; TTM through Mar 2026 was 9.01%, a 187.0% decrease from a year earlier, with the FY2025 full-year figure at 9.51%, down 135.0% from the prior year.
• Return on Capital Employed retreated to 9.01% in Q1 2026 per UTMD's latest filing, from 9.53% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 17.88% in Q3 2022 and bottomed at 9.01% in Q1 2026.
• The 5-year median for Return on Capital Employed is 12.48% (2024), against an average of 13.3%.
• Across the five-year window, Return on Capital Employed surged 483 bps in 2022 and plunged 414 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 17.18% in 2022, then declined by 24 bps to 13.04% in 2023, then decreased by 15 bps to 11.11% in 2024, then declined by 14 bps to 9.53% in 2025, then declined by 5 bps to 9.01% in 2026.
• Per Business Quant, the three latest UTMD Return on Capital Employed figures stand at 9.01% (Q1 2026), 9.53% (Q4 2025), and 10.04% (Q3 2025).